Literature DB >> 33562479

Made in Germany: A Quality Indicator Not Only in the Automobile Industry But Also When It Comes to Skin Replacement: How an Automobile Textile Research Institute Developed a New Skin Substitute.

Herbert Leopold Haller1, Matthias Rapp2, Daniel Popp3, Sebastian Philipp Nischwitz3, Lars Peter Kamolz3.   

Abstract

Successful research and development cooperation between a textile research institute, the German Federal Ministry of Education and Research via the Center for Biomaterials and Organ Substitutes, the University of Tübingen, and the Burn Center of Marienhospital, Stuttgart, Germany, led to the development of a fully synthetic resorbable temporary epidermal skin substitute for the treatment of burns, burn-like syndromes, donor areas, and chronic wounds. This article describes the demands of the product and the steps that were taken to meet these requirements. The material choice was based on the degradation and full resorption of polylactides to lactic acid and its salts. The structure and morphology of the physical, biological, and degradation properties were selected to increase the angiogenetic abilities, fibroblasts, and extracellular matrix generation. Water vapor permeability and plasticity were adapted for clinical use. The available scientific literature was screened for the use of this product. A clinical application demonstrated pain relief paired with a reduced workload, fast wound healing with a low infection rate, and good cosmetic results. A better understanding of the product's degradation process explained the reduction in systemic oxidative stress shown in clinical investigations compared to other dressings, positively affecting wound healing time and reducing the total area requiring skin grafts. Today, the product is in clinical use in 37 countries. This article describes its development, the indications for product growth over time, and the scientific foundation of treatments.

Entities:  

Keywords:  analgesia; burn; donor area; lactormone; oxidative stress reduction; polylactide; reduced infection; stabilization; wounds

Mesh:

Year:  2021        PMID: 33562479      PMCID: PMC7914466          DOI: 10.3390/medicina57020143

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  86 in total

1.  The use of Suprathel(®) in deep dermal burns: first results of a prospective study.

Authors:  M Keck; H F Selig; D B Lumenta; L P Kamolz; M Mittlböck; M Frey
Journal:  Burns       Date:  2011-11-10       Impact factor: 2.744

2.  [New strategies for the treatment of thermally injured hands with regard to the epithelial substitute Suprathel].

Authors:  C Uhlig; M Rapp; K-K Dittel
Journal:  Handchir Mikrochir Plast Chir       Date:  2007-10       Impact factor: 1.018

3.  Inhalation injury or mechanical ventilation: which is the true killer in burn patients?

Authors:  D P Mackie
Journal:  Burns       Date:  2013-09-14       Impact factor: 2.744

Review 4.  Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies.

Authors:  Patricia Rousselle; Fabienne Braye; Guila Dayan
Journal:  Adv Drug Deliv Rev       Date:  2018-07-05       Impact factor: 15.470

5.  The role of pore size on vascularization and tissue remodeling in PEG hydrogels.

Authors:  Yu-Chieh Chiu; Ming-Huei Cheng; Holger Engel; Shu-Wei Kao; Jeffery C Larson; Shreya Gupta; Eric M Brey
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

Review 6.  Suprathel(®) for severe burns in the elderly: Case report and review of the literature.

Authors:  S Fischer; T Kremer; J Horter; A Schaefer; B Ziegler; U Kneser; C Hirche
Journal:  Burns       Date:  2016-05-24       Impact factor: 2.744

7.  Use of a copolymer dressing on superficial and partial-thickness burns in a paediatric population.

Authors:  M Everett; S Massand; W Davis; B Burkey; P M Glat
Journal:  J Wound Care       Date:  2015-07       Impact factor: 2.072

8.  Toxic shock syndrome associated with use of Biobrane in a scald burn victim.

Authors:  J Weinzweig; L J Gottlieb; T J Krizek
Journal:  Burns       Date:  1994-04       Impact factor: 2.744

9.  Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.

Authors:  Zhi Zhang; Tania M Garron; Xiao-Jian Li; Yan Liu; Xiong Zhang; Ye-Yang Li; Wei-Shi Xu
Journal:  Burns       Date:  2009-01-23       Impact factor: 2.744

10.  Reactive Oxygen Species Mediated Prostaglandin E2 Contributes to Acute Response of Epithelial Injury.

Authors:  Yi-Ping Hu; Yin-Bo Peng; Yi-Fan Zhang; Ying Wang; Wei-Rong Yu; Min Yao; Xiu-Jun Fu
Journal:  Oxid Med Cell Longev       Date:  2017-02-09       Impact factor: 6.543

View more
  1 in total

1.  The successful use of polylactide wound dressings for chronic lower leg wounds: A retrospective analysis.

Authors:  Sebastian P Nischwitz; Daniel Popp; David Shubitidze; Hanna Luze; Robert Zrim; Klaus Klemm; Matthias Rapp; Herbert L Haller; Manuel Feisst; Lars-Peter Kamolz
Journal:  Int Wound J       Date:  2021-11-08       Impact factor: 3.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.